Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

NCT06775834 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG: HRS-1893

Sponsor

Shandong Suncadia Medicine Co., Ltd.